Canada Patent Protections In Spotlight As PhRMA Seeks Addition To “Priority Watch List”

The drug industry sees a not-so-friendly neighbor to the North and wants help from the Office of the U.S. Trade Representative to get Canada to change its “promise utility doctrine.”

India is once again on the top of the pharmaceutical industry’s list of countries that do not provide enough protection of intellectual property rights. But this year it is joined by an unlikely foe: Canada.

The Pharmaceutical Research and Manufacturers of America focused on the two countries at a public hearing of the Office of...

Welcome to Pink Sheet

Create an account to read this article

More from Europe

More from Geography